Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...

Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is expected to exceed $850 billion worldwide by 2032. Driving forces behind this ...

The news that the organization led a $35 million funding round for London-based Portal Biotech came about two weeks ago. Portal Biotech’s focus is on the field of proteomics, which is the study of ...